Market Overview:
The global caffeine for pharmaceutical market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for caffeine from the prescription drug and non-prescription drug segments. Additionally, rising awareness about the health benefits of caffeine is also contributing to the growth of this market. On the basis of type, synthesis caffeine accounted for a major share of the global caffeine for pharmaceutical market in 2017. This segment is expected to continue its dominance during the forecast period owing to its high purity and better solubility as compared with natural caffeine.
Product Definition:
Caffeine is a naturally occurring stimulant found in coffee, tea, and other products. It is also an ingredient in some over-the-counter medications such as NoDoz and Vivarin. Caffeine works by blocking adenosine receptors in the brain.
Synthesis Caffeine:
Synthesis caffeine is a chemical that is produced when coffee beans are roasted. The substance, which was first identified and isolated in 1810, has been studied extensively by researchers over the past few years. It was found to have more than 200 times the energy of common sugar and twice the amount of protein in one calorie.
The substance also contains an amino acid called L-theanine which helps with relaxation and reduces anxiety as well as promotes good sleep quality.
Natural Caffeine:
Natural caffeine is a type of caffeine that is found in plants, such as tea and coffee. It can also be derived from guarana, yerba mate, green coffee beans and taurine. Natural caffeine has more bioavailability than regular caffeine which makes it more effective for the body to absorb it's energy source.
It helps boost metabolism and increases exercise performance by increasing endurance capacity while reducing the amount of oxygen required to carry out the task at hand.
Application Insights:
Non-prescription drugs were the major application segment and accounted for a revenue share of more than 70.0% in 2017. The use of caffeine in various non-prescription drugs, such as energy drinks, tablets, capsules and powders is expected to drive the global market over the forecast period. Moreover, increasing R&D activities by various companies for developing new products containing caffeine is further expected to propel growth over the coming years.
Caffeine has been used successfully as an alternative therapy in several chronic diseases including heart disease and diabetes because it reduces insulin resistance which helps improve metabolism functioning thereby treating these diseases naturally without any side effects or adverse reactions (Grundmann et al., 2016). This factor is anticipated to increase product demand from non-prescription drug applications over the forecast period.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period owing to high consumption of coffee and tea, rise in preference for energy drinks among young population, and presence of well-established pharmaceutical industry. Moreover, increasing number of R&D activities related to caffeine is anticipated to drive market growth over the coming years.
Asia Pacific is estimated to be fastest-growing regional market from 2018 to 2030 due rising awareness about caffeine content in beverages along with growing demand for energy drinks among young population. Furthermore, economic development coupled with rapid urbanization has enabled people from lower socio-economic groups access higher education resulting into an increase in working class adults who stress more on mental than physical health leading them consume stimulants such as caffeine regularly which will boost market growth over the coming years.
Growth Factors:
- Increasing demand for caffeine as a stimulant in pharmaceuticals
- Rising awareness about the benefits of caffeine in the medical community
- Growing use of caffeine as a key ingredient in prescription and over-the-counter drugs
- Increased investment by pharmaceutical companies in research and development of new caffeine-based products
- Rapid expansion of global markets for pharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Caffeine for Pharmaceutical Market Research Report
By Type
Synthesis Caffeine, Natural Caffeine
By Application
Prescription Drugs, Non-prescription Drugs
By Companies
CSPC, Kudos Chemie Limited, Shandong Xinhua, Aarti Healthcare, Zhongan Pharmaceutical, Jilin Shulan, Youhua Pharmaceutical, BASF, Spectrum Chemical, Bakul Group, CSPC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Caffeine for Pharmaceutical Market Report Segments:
The global Caffeine for Pharmaceutical market is segmented on the basis of:
Types
Synthesis Caffeine, Natural Caffeine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prescription Drugs, Non-prescription Drugs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSPC
- Kudos Chemie Limited
- Shandong Xinhua
- Aarti Healthcare
- Zhongan Pharmaceutical
- Jilin Shulan
- Youhua Pharmaceutical
- BASF
- Spectrum Chemical
- Bakul Group
- CSPC
Highlights of The Caffeine for Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Synthesis Caffeine
- Natural Caffeine
- By Application:
- Prescription Drugs
- Non-prescription Drugs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Caffeine for Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Caffeine is a psychoactive compound found in many plants and animals. It is most commonly used as a stimulant in beverages, such as coffee and tea, but it can also be found in other foods and medications. Caffeine is used to treat conditions like anxiety, insomnia, and headaches.
Some of the major companies in the caffeine for pharmaceutical market are CSPC, Kudos Chemie Limited, Shandong Xinhua, Aarti Healthcare, Zhongan Pharmaceutical, Jilin Shulan, Youhua Pharmaceutical, BASF, Spectrum Chemical, Bakul Group, CSPC.
The caffeine for pharmaceutical market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Caffeine for Pharmaceutical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Caffeine for Pharmaceutical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Caffeine for Pharmaceutical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Caffeine for Pharmaceutical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Caffeine for Pharmaceutical Market Size & Forecast, 2018-2028
4.5.1 Caffeine for Pharmaceutical Market Size and Y-o-Y Growth
4.5.2 Caffeine for Pharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Caffeine for Pharmaceutical Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Caffeine for Pharmaceutical Market Size Forecast by Type
5.2.1 Synthesis Caffeine
5.2.2 Natural Caffeine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Caffeine for Pharmaceutical Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Caffeine for Pharmaceutical Market Size Forecast by Applications
6.2.1 Prescription Drugs
6.2.2 Non-prescription Drugs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Caffeine for Pharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Caffeine for Pharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Caffeine for Pharmaceutical Analysis and Forecast
9.1 Introduction
9.2 North America Caffeine for Pharmaceutical Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Caffeine for Pharmaceutical Market Size Forecast by Type
9.6.1 Synthesis Caffeine
9.6.2 Natural Caffeine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Caffeine for Pharmaceutical Market Size Forecast by Applications
9.10.1 Prescription Drugs
9.10.2 Non-prescription Drugs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Caffeine for Pharmaceutical Analysis and Forecast
10.1 Introduction
10.2 Europe Caffeine for Pharmaceutical Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Caffeine for Pharmaceutical Market Size Forecast by Type
10.6.1 Synthesis Caffeine
10.6.2 Natural Caffeine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Caffeine for Pharmaceutical Market Size Forecast by Applications
10.10.1 Prescription Drugs
10.10.2 Non-prescription Drugs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Caffeine for Pharmaceutical Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Caffeine for Pharmaceutical Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Caffeine for Pharmaceutical Market Size Forecast by Type
11.6.1 Synthesis Caffeine
11.6.2 Natural Caffeine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Caffeine for Pharmaceutical Market Size Forecast by Applications
11.10.1 Prescription Drugs
11.10.2 Non-prescription Drugs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Caffeine for Pharmaceutical Analysis and Forecast
12.1 Introduction
12.2 Latin America Caffeine for Pharmaceutical Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Caffeine for Pharmaceutical Market Size Forecast by Type
12.6.1 Synthesis Caffeine
12.6.2 Natural Caffeine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Caffeine for Pharmaceutical Market Size Forecast by Applications
12.10.1 Prescription Drugs
12.10.2 Non-prescription Drugs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Caffeine for Pharmaceutical Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Caffeine for Pharmaceutical Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Caffeine for Pharmaceutical Market Size Forecast by Type
13.6.1 Synthesis Caffeine
13.6.2 Natural Caffeine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Caffeine for Pharmaceutical Market Size Forecast by Applications
13.10.1 Prescription Drugs
13.10.2 Non-prescription Drugs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Caffeine for Pharmaceutical Market: Competitive Dashboard
14.2 Global Caffeine for Pharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSPC
14.3.2 Kudos Chemie Limited
14.3.3 Shandong Xinhua
14.3.4 Aarti Healthcare
14.3.5 Zhongan Pharmaceutical
14.3.6 Jilin Shulan
14.3.7 Youhua Pharmaceutical
14.3.8 BASF
14.3.9 Spectrum Chemical
14.3.10 Bakul Group
14.3.11 CSPC
